+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aquaculture Therapeutics Market by Therapeutic Type, Species, Mode of Administration, Application, Distribution Channel - Global Forecast 2026-2032- Product Image
Aquaculture Therapeutics Market by Therapeutic Type, Species, Mode of Administration, Application, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Aquaculture Therapeutics Market by Therapeutic Type, Species, Mode of Administration, Application, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5305516
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Aquaculture Therapeutics Market is projected to reach USD 3.26 Billion in 2026. It is expected to continue growing at a CAGR of 9.37%, reaching USD 5.63 Billion by 2032.

Aquaculture therapeutics are becoming a strategic foundation for sustainable seafood production as farmed aquatic animals now represent the fastest-growing pillar of global aquatic food supply. FAO reported total fisheries and aquaculture production of 223.2 million tonnes in 2022, with aquaculture reaching 130.9 million tonnes, including 94.4 million tonnes of aquatic animals and 36.5 million tonnes of algae. This scale makes disease prevention, biosecurity, vaccines, parasiticides, diagnostics, medicated feeds, probiotics, immunostimulants, and approved antimicrobial stewardship central to food security and farm profitability.

The market is shaped by rising seafood demand, intensifying production systems, climate-driven disease pressure, and tighter residue and antimicrobial resistance controls. Buyers increasingly favor therapeutics supported by regulatory compliance, veterinary oversight, evidence-based dosing, validated withdrawal periods, and integrated health management. For industry leaders, growth depends on shifting from reactive treatment to preventive aquatic animal health programs that combine diagnostics, vaccination, nutrition, water-quality management, farm biosecurity, and responsible medicine use.

Transformative Shifts in the Aquaculture Therapeutics Landscape

The aquaculture therapeutics landscape is moving from volume-led treatment models toward precision health management. Producers are adopting vaccination, pathogen surveillance, rapid diagnostics, functional feeds, probiotics, and farm-level biosecurity to reduce mortality and limit reliance on antibiotics. This shift is reinforced by global concern over antimicrobial resistance and by import-market scrutiny of drug residues in fish and shrimp.

Transformative change is also coming from species diversification and climate volatility. Salmon, tilapia, carp, catfish, trout, shrimp, and marine finfish face different pathogen profiles, which requires localized therapeutic protocols, species-specific dosing, and country-level regulatory approvals. Warmer waters, extreme weather, salinity shifts, harmful algal blooms, and oxygen stress can increase disease susceptibility, making therapeutics more closely linked with environmental monitoring, epidemiological intelligence, and risk forecasting.

Cumulative Impact of Artificial Intelligence on Aquaculture Therapeutics

Artificial intelligence is strengthening aquaculture therapeutics by turning farm data into earlier disease warnings and more targeted interventions. Computer vision, acoustic sensors, water-quality probes, feeding systems, satellite data, and production records can help identify abnormal swimming, reduced appetite, stress indicators, and mortality patterns before outbreaks escalate. When paired with diagnostics and veterinary review, these tools can improve treatment timing, optimize dosing decisions, and reduce unnecessary medicine use.

The cumulative impact is operational as well as scientific. AI-enabled epidemiological models support site-level risk scoring, vaccine planning, sea-lice monitoring, antimicrobial stewardship, mortality analysis, and inventory forecasting for therapeutic products. However, AI should complement, not replace, laboratory confirmation, licensed veterinary decisions, and national medicine regulations. The strongest advantage will come from validated datasets, interoperable farm records, traceable decisions, and transparent governance of farm health data.

Key Regional Insights for Aquaculture Therapeutics

Asia-Pacific is the center of gravity for aquaculture therapeutics because Asia accounts for the dominant share of global farmed aquatic animal production, led by China, India, Indonesia, Vietnam, Bangladesh, and other high-output producers. Dense production of carp, tilapia, catfish, shrimp, and marine species creates strong demand for diagnostics, vaccines where available, pond health tools, biosecurity programs, and approved treatments for bacterial, viral, fungal, and parasitic conditions. Export-facing shrimp and finfish producers in the region are also under increasing pressure to document residue compliance and responsible antimicrobial use.

North America emphasizes regulated therapeutics, veterinary oversight, and high-value finfish production, particularly salmonids, trout, catfish, and shellfish, with aquatic animal health closely linked to food safety and environmental permitting. Latin America, led by Chile, Brazil, Mexico, and Ecuador, combines salmon, tilapia, and shrimp scale with rising biosecurity investment and disease surveillance, especially for viral and bacterial risks in intensive systems. Europe is defined by stringent residue rules, advanced vaccination programs, strong traceability, and mature salmon, trout, seabass, and seabream farming. The Middle East is expanding recirculating aquaculture systems, marine aquaculture, and desert aquaculture to support food security, while Africa is building tilapia and catfish capacity, creating demand for affordable diagnostics, practical veterinary access, and field-ready disease-control solutions.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is a high-priority arena because shrimp, pangasius, tilapia, and marine finfish are deeply integrated with export markets and smallholder production. The region’s therapeutic demand is tied to early mortality syndrome management, viral disease surveillance, pond biosecurity, hatchery health, and residue-compliant treatment practices. GCC countries are investing in food security, recirculating aquaculture systems, and controlled-environment production, creating demand for water-quality-linked therapeutics, preventive health systems, and rapid diagnostics suited to high-salinity and arid operating conditions.

The European Union sets influential standards for antimicrobial stewardship, veterinary medicines, environmental protection, and seafood traceability, shaping supplier expectations beyond Europe through import requirements and sustainability programs. BRICS economies combine large domestic consumption, expanding aquaculture output, and growing biotechnology capabilities, making them important for localized manufacturing, diagnostics adoption, and regulatory harmonization. G7 and NATO members contribute advanced research capacity, regulatory science, aquatic health surveillance, diagnostics, and cold-chain infrastructure, supporting innovation in vaccines, precision dosing, fish welfare, and responsible aquatic animal health management.

Key Country Insights for Aquaculture Therapeutics

The United States and Canada are characterized by regulated aquatic animal health practices, strong diagnostic institutions, and demand for approved treatments across salmonids, catfish, trout, and shellfish. Mexico and Brazil are expanding tilapia, shrimp, and marine aquaculture, where improved veterinary access, biosecurity, hatchery health, and farm training can strengthen therapeutic outcomes. The United Kingdom, Germany, France, Italy, and Spain operate under rigorous European frameworks that favor vaccines, diagnostics, residue compliance, fish welfare, and reduced antimicrobial dependence across salmon, trout, seabass, seabream, shellfish, and emerging land-based systems.

Russia has cold-water finfish and emerging domestic aquaculture priorities, while China remains the largest aquaculture producer and a major driver of therapeutics demand across carp, shrimp, tilapia, and marine species. India’s shrimp and carp industries require scalable disease surveillance, hatchery biosecurity, and responsible treatment practices to protect exports and domestic supply. Japan and South Korea emphasize high-value marine species, technology-enabled monitoring, strict food safety expectations, and intensive coastal aquaculture management. Australia combines salmon, barramundi, tuna, and prawn farming with strong biosecurity controls, aquatic animal health surveillance, and premium-market traceability requirements.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize preventive health programs that combine vaccination where available, routine diagnostics, pathogen monitoring, biosecurity audits, water-quality control, and nutrition-based immune support. Therapeutic portfolios should be aligned with species, pathogen risk, production system, and country-specific approvals. Companies that document efficacy, correct dosing, withdrawal periods, residue compliance, adverse-event monitoring, and resistance management will be better positioned with regulators, retailers, veterinarians, and export buyers.

Commercial teams should invest in farmer education, veterinary partnerships, and digital decision support that links treatment recommendations to diagnostics, environmental data, and farm records. Manufacturers should build regional evidence through field trials, pharmacovigilance, post-market surveillance, and clear stewardship guidance for antimicrobials and parasiticides. The most defensible growth strategy is to offer integrated aquaculture health solutions rather than stand-alone products, especially in markets facing climate-related disease volatility, higher stocking density, and stricter sustainability requirements.

Research Methodology

This executive summary is based on a structured review of public, authoritative sources, including FAO fisheries and aquaculture statistics, WOAH aquatic animal health guidance, national veterinary medicine and food safety frameworks, seafood trade patterns, and peer-reviewed findings on aquatic disease management, antimicrobial stewardship, vaccination, probiotics, diagnostics, and biosecurity. Insights were assessed for relevance to therapeutics, species coverage, production systems, disease pressure, regulatory requirements, and regional demand drivers.

The methodology emphasizes triangulation rather than unsupported market claims. Production trends, regulatory signals, residue-control requirements, disease-risk factors, climate-related stressors, and technology adoption patterns were compared across regions, economic groups, and countries. Conclusion

Aquaculture therapeutics are entering a more disciplined and technology-enabled phase as global aquaculture becomes essential to seafood supply. The strongest opportunities are linked to preventive care, compliant therapeutics, diagnostics, vaccines, biosecurity, functional nutrition, and integrated farm health management that reduce losses while supporting food safety, animal welfare, and sustainability.

Future competitiveness will depend on evidence, regulatory alignment, and practical deployment at farm level. Organizations that combine science-backed products with AI-enabled monitoring, veterinary stewardship, residue compliance, and region-specific disease expertise will be best positioned to serve producers, protect aquatic animal health, and support resilient global seafood systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Aquaculture Therapeutics Market, by Therapeutic Type
7.1. Antibiotic
7.1.1. Broad Spectrum Antibiotic
7.1.2. Narrow Spectrum Antibiotic
7.2. Disinfectant
7.2.1. Chlorine
7.2.2. Quaternary Ammonium Compound
7.3. Immunostimulant
7.3.1. Beta Glucan
7.3.2. Herbal Extract
7.4. Probiotic
7.4.1. Bacterial Probiotic
7.4.2. Yeast Probiotic
7.5. Vaccine
7.5.1. Inactivated Vaccine
7.5.2. Live Attenuated Vaccine
7.5.3. Recombinant Vaccine
8. Aquaculture Therapeutics Market, by Species
8.1. Crustacean
8.1.1. Prawn
8.1.2. Shrimp
8.2. Fish
8.2.1. Carp
8.2.2. Salmon
8.2.3. Tilapia
8.3. Mollusk
8.3.1. Mussel
8.3.2. Oyster
9. Aquaculture Therapeutics Market, by Mode Of Administration
9.1. Immersion
9.2. Injection
9.3. Oral
10. Aquaculture Therapeutics Market, by Application
10.1. Curative
10.2. Preventive
11. Aquaculture Therapeutics Market, by Distribution Channel
11.1. Offline
11.2. Online
12. Asia-Pacific Aquaculture Therapeutics Market
13. North America Aquaculture Therapeutics Market
14. Latin America Aquaculture Therapeutics Market
15. Europe Aquaculture Therapeutics Market
16. Middle East Aquaculture Therapeutics Market
17. Africa Aquaculture Therapeutics Market
18. ASEAN Aquaculture Therapeutics Market
19. GCC Aquaculture Therapeutics Market
20. European Union Aquaculture Therapeutics Market
21. BRICS Aquaculture Therapeutics Market
22. G7 Aquaculture Therapeutics Market
23. NATO Aquaculture Therapeutics Market
24. United States Aquaculture Therapeutics Market
25. Canada Aquaculture Therapeutics Market
26. Mexico Aquaculture Therapeutics Market
27. Brazil Aquaculture Therapeutics Market
28. United Kingdom Aquaculture Therapeutics Market
29. Germany Aquaculture Therapeutics Market
30. France Aquaculture Therapeutics Market
31. Russia Aquaculture Therapeutics Market
32. Italy Aquaculture Therapeutics Market
33. Spain Aquaculture Therapeutics Market
34. China Aquaculture Therapeutics Market
35. India Aquaculture Therapeutics Market
36. Japan Aquaculture Therapeutics Market
37. Australia Aquaculture Therapeutics Market
38. South Korea Aquaculture Therapeutics Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. ACD Pharma
40.2. AgriSea
40.3. Aqua Pharma Group
40.4. AquaBounty Technologies, Inc.
40.5. Aquaculture of Texas Inc
40.6. Aquafarm Equipment AS
40.7. Benchmark Holdings PLC
40.8. Biofeyn
40.9. Bionor Laboratories
40.10. Blue Ocean Mariculture
40.11. Ceva Santé Animale
40.12. Elanco Animal Health Incorporated
40.13. Innovasea Systems Inc.
40.14. Kennebec River Biosciences
40.15. Merck & Co., Inc.
40.16. Nutreco NV
40.17. OCEANIUM
40.18. Proteon Pharmaceuticals S.A.
40.19. Syndel Laboratories
40.20. TeOra Pte. Ltd.
40.21. TunaTech GmbH
40.22. Unibio Group
40.23. ViAqua Therapeutics
40.24. VXL DRUGS PRIVATE LIMITED
40.25. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL AQUACULTURE THERAPEUTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL AQUACULTURE THERAPEUTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL AQUACULTURE THERAPEUTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL AQUACULTURE THERAPEUTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL AQUACULTURE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL AQUACULTURE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2025 VS 2032 (%)
FIGURE 17. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 23. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL AQUACULTURE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AQUACULTURE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL AQUACULTURE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANTIBIOTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANTIBIOTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BROAD SPECTRUM ANTIBIOTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BROAD SPECTRUM ANTIBIOTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BROAD SPECTRUM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NARROW SPECTRUM ANTIBIOTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NARROW SPECTRUM ANTIBIOTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NARROW SPECTRUM ANTIBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DISINFECTANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DISINFECTANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DISINFECTANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CHLORINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CHLORINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CHLORINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL QUATERNARY AMMONIUM COMPOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL QUATERNARY AMMONIUM COMPOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL QUATERNARY AMMONIUM COMPOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IMMUNOSTIMULANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IMMUNOSTIMULANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNOSTIMULANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BETA GLUCAN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BETA GLUCAN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BETA GLUCAN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HERBAL EXTRACT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HERBAL EXTRACT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HERBAL EXTRACT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PROBIOTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PROBIOTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PROBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BACTERIAL PROBIOTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BACTERIAL PROBIOTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BACTERIAL PROBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL YEAST PROBIOTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL YEAST PROBIOTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL YEAST PROBIOTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL INACTIVATED VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL INACTIVATED VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL LIVE ATTENUATED VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL LIVE ATTENUATED VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL LIVE ATTENUATED VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RECOMBINANT VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RECOMBINANT VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RECOMBINANT VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CRUSTACEAN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CRUSTACEAN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CRUSTACEAN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PRAWN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PRAWN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PRAWN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SHRIMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SHRIMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SHRIMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL FISH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL FISH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL FISH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CARP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CARP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CARP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SALMON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SALMON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SALMON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TILAPIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TILAPIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TILAPIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MOLLUSK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MOLLUSK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MOLLUSK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MUSSEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MUSSEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MUSSEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL OYSTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL OYSTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL OYSTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IMMERSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IMMERSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IMMERSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL INJECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL INJECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL INJECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CURATIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CURATIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CURATIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PREVENTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PREVENTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PREVENTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 156. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 157. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 158. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 159. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 160. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 161. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 162. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 163. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 164. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 165. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 166. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. EUROPE AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 184. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 185. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 186. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 187. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 188. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 189. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 190. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 191. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 192. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 193. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 194. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 198. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 199. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 200. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 201. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 202. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 203. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 204. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 205. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 206. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 207. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 208. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. ASEAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 211. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 212. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 213. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 214. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 215. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 216. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 217. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 218. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 219. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 220. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 221. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 222. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. GCC AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 238. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 239. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 240. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 241. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 242. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 243. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 244. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 245. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 246. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 247. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 248. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 249. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 250. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. BRICS AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 253. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 254. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 255. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 256. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 257. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 258. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 259. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 260. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 261. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 262. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 263. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 264. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. G7 AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 266. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 267. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 268. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 269. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 270. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 271. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 272. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 273. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 274. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 275. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 276. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 277. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 278. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 279. NATO AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 294. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 295. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 296. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 297. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 298. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 299. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 300. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 301. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 302. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 303. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 304. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 305. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 306. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 307. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 308. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 309. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 310. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 311. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 312. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 313. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 314. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 315. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 316. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 317. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 318. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 319. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 320. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 321. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 322. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 323. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 324. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 325. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 326. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 327. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 328. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 329. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 330. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 331. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 332. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 333. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 334. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 335. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 336. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 337. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 338. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 339. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 341. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 342. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 343. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
TABLE 344. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY CRUSTACEAN, 2018-2032 (USD MILLION)
TABLE 345. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY FISH, 2018-2032 (USD MILLION)
TABLE 346. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY MOLLUSK, 2018-2032 (USD MILLION)
TABLE 347. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 348. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 349. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 350. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 351. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2032 (USD MILLION)
TABLE 352. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY ANTIBIOTIC, 2018-2032 (USD MILLION)
TABLE 353. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY DISINFECTANT, 2018-2032 (USD MILLION)
TABLE 354. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY IMMUNOSTIMULANT, 2018-2032 (USD MILLION)
TABLE 355. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PROBIOTIC, 2018-2032 (USD MILLION)
TABLE 356. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY VACCINE, 2018-2032 (USD MILLION)
TABLE 357. G

Companies Mentioned

The companies featured in this Aquaculture Therapeutics market report include:
  • ACD Pharma
  • AgriSea
  • Aqua Pharma Group
  • AquaBounty Technologies, Inc.
  • Aquaculture of Texas Inc
  • Aquafarm Equipment AS
  • Benchmark Holdings PLC
  • Biofeyn
  • Bionor Laboratories
  • Blue Ocean Mariculture
  • Ceva Santé Animale
  • Elanco Animal Health Incorporated
  • Innovasea Systems Inc.
  • Kennebec River Biosciences
  • Merck & Co., Inc.
  • Nutreco NV
  • OCEANIUM
  • Proteon Pharmaceuticals S.A.
  • Syndel Laboratories
  • TeOra Pte. Ltd.
  • TunaTech GmbH
  • Unibio Group
  • ViAqua Therapeutics
  • VXL DRUGS PRIVATE LIMITED
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.26 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.63 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Aquaculture Market Size, Share, Trends and Forecast by Fish Type, Environment, Distribution Channel, and Region, 2026-2034 - Product Image

Aquaculture Market Size, Share, Trends and Forecast by Fish Type, Environment, Distribution Channel, and Region, 2026-2034

  • Report
  • 137 Pages
  • Global
From
United States Aquaculture Market Report by Environment, Type, End Use, States and Company Analysis, 2025-2033 - Product Image

United States Aquaculture Market Report by Environment, Type, End Use, States and Company Analysis, 2025-2033

  • Report
  • 200 Pages
  • United States
From
North America Aquaculture Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type and Culture Environment - Product Image

North America Aquaculture Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type and Culture Environment

  • Report
  • 123 Pages
  • North America
From
Aquaculture - Global Strategic Business Report - Product Image

Aquaculture - Global Strategic Business Report

  • Report
  • 312 Pages
  • Global
From
Aquaculture Immunostimulant Market - Global Forecast 2026-2032 - Product Image

Aquaculture Immunostimulant Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.